What is Occidental Pet's earnings per share (EPS)?

Occidental Pet (OXY) reported diluted earnings per share of $1.61 for fiscal year 2025. This represents a -34.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Occidental Pet Financials

OXY

Source SEC Filings (10-K/10-Q) Data as of Mar 31, 2026 Currency USD FYE December

This page shows Occidental Pet (OXY) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 19 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI OXY FY2025 2026-05-05

Heavy depreciation and disciplined deleveraging make cash flow look sturdier than earnings even as reinvestment absorbs more of it.

From FY2023 to FY2025, operating cash flow slipped from $12.3B to $10.5B while net income fell from $4.7B to $2.4B; with annual depreciation still running at $6.4B to $7.5B, reported profit is swinging more than the cash the asset base is producing. Because capital spending also climbed from $5.7B to $6.4B, only part of that cash resilience reached free cash flow, which narrowed from $6.6B to $4.1B.

The balance sheet is less debt-led than it was in FY2021: long-term debt fell from $29.4B to $21.4B and debt-to-equity improved from 1.4x to 0.6x, so a larger share of the company is financed by equity rather than creditors. Yet short-term liquidity remains tighter than long-term solvency, with the current ratio below 1.0 since FY2023, meaning near-term obligations depend more on ongoing cash generation than on a working-capital buffer.

Capital allocation has shifted away from repurchases and toward the asset base: buybacks dropped from $1.8B in FY2023 to $0 in FY2025 while capital expenditures rose to $6.4B. With shares outstanding increasing from 879.5M to 986.3M over the same period, per-share results recently had little help from share count reduction.

Financial Health Signals

Financial Health Score 34/100

Scored as: Energy peer group

Scored against energy companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Occidental Pet's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Growth

Leverage

Liquidity

Cash Flow

Piotroski F-Score Partial

4/8

Occidental Pet passes 4 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed

4.45x

For every $1 of reported earnings, Occidental Pet generates $4.45 in operating cash flow ($10.5B OCF vs $2.4B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$21.6B

YoY-1.9%

5Y CAGR+3.9%

10Y CAGR+5.6%

Occidental Pet generated $21.6B in revenue in fiscal year 2025. This represents a decrease of 1.9% from the prior year.

EBITDA

N/A

Net Income

$2.4B

YoY-23.0%

Occidental Pet reported $2.4B in net income in fiscal year 2025. This represents a decrease of 23.0% from the prior year.

EPS (Diluted)

$1.61

YoY-34.0%

Occidental Pet earned $1.61 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 34.0% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$4.1B

YoY-20.7%

5Y CAGR+23.7%

Occidental Pet generated $4.1B in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 20.7% from the prior year.

Cash & Debt

$2.0B

YoY-7.4%

5Y CAGR-0.4%

10Y CAGR-4.7%

Occidental Pet held $2.0B in cash against $20.6B in long-term debt as of fiscal year 2025.

Dividends Per Share

$0.96

YoY+9.1%

5Y CAGR+3.2%

10Y CAGR-10.7%

Occidental Pet paid $0.96 per share in dividends in fiscal year 2025. This represents an increase of 9.1% from the prior year.

Shares Outstanding

986M

YoY+5.1%

5Y CAGR+1.1%

10Y CAGR+2.6%

Occidental Pet had 986M shares outstanding in fiscal year 2025. This represents an increase of 5.1% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

N/A

Net Margin

11.0%

YoY-3.0pp

5Y CAGR+94.3pp

10Y CAGR+73.7pp

Occidental Pet's net profit margin was 11.0% in fiscal year 2025, showing the share of revenue converted to profit. This is down 3.0 percentage points from the prior year.

Return on Equity

6.6%

YoY-2.4pp

5Y CAGR+86.4pp

10Y CAGR+38.7pp

Occidental Pet's ROE was 6.6% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 2.4 percentage points from the prior year.

Capital Allocation

R&D Spending

N/A

Share Buybacks

YoY-100.0%

Occidental Pet spent $0 on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 100.0% from the prior year.

Capital Expenditures

$6.4B

YoY+2.6%

5Y CAGR+20.4%

10Y CAGR+2.0%

Occidental Pet invested $6.4B in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 2.6% from the prior year.

OXY Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$21.6B-1.9%	$22.0B-4.9%	$23.2B-36.8%	$36.6B+41.1%	$26.0B+45.7%	$17.8B
Cost of Revenue	N/A	$3.1B+0.2%	$3.1B-4.8%	$3.3B+18.1%	$2.8B+15.1%	$2.4B
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$986.0M+2.7%	$960.0M-2.7%	$987.0M+4.4%	$945.0M+9.5%	$863.0M-0.1%	$864.0M
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	$1.1B-7.7%	$1.2B+22.2%	$957.0M-7.1%	$1.0B-36.2%	$1.6B+13.3%	$1.4B
Income Tax	$1.0B-11.8%	$1.2B-12.9%	$1.3B+63.6%	$813.0M-11.1%	$915.0M+142.1%	-$2.2B
Net Income	$2.4B-23.0%	$3.1B-34.5%	$4.7B-64.7%	$13.3B+473.0%	$2.3B+115.7%	-$14.8B
EPS (Diluted)	$1.61-34.0%	$2.44-37.4%	$3.90-68.5%	$12.40+684.8%	$1.58+109.3%	$-17.06

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Revenue	$5.2B+83.4%	$2.9B-57.0%	$6.6B+3.3%	$6.4B+12.4%	$5.7B+177.7%	$2.1B-71.4%	$7.2B+5.2%	$6.8B
Cost of Revenue	N/A	N/A	$812.0M-4.1%	$847.0M+5.7%	$801.0M+62.1%	$494.0M-44.4%	$889.0M-2.3%	$910.0M
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$245.0M+33.2%	$184.0M-33.6%	$277.0M-2.5%	$284.0M+17.8%	$241.0M+38.5%	$174.0M-35.1%	$268.0M+3.5%	$259.0M
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	$432.0M+93.7%	$223.0M-17.4%	$270.0M-2.2%	$276.0M-11.0%	$310.0M-3.4%	$321.0M+2.9%	$312.0M+23.8%	$252.0M
Income Tax	$154.0M+92.5%	$80.0M-75.3%	$324.0M+20.0%	$270.0M-22.2%	$347.0M+633.8%	-$65.0M-114.3%	$454.0M-2.4%	$465.0M
Net Income	$3.4B+2846.5%	$114.0M-86.5%	$842.0M+79.9%	$468.0M-50.5%	$945.0M+887.5%	-$120.0M-110.5%	$1.1B-2.6%	$1.2B
EPS (Diluted)	$3.13	N/A	$0.65+150.0%	$0.26-66.2%	$0.77	N/A	$0.98-4.9%	$1.03

OXY Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$84.2B-1.5%	$85.4B+15.5%	$74.0B+1.9%	$72.6B-3.2%	$75.0B-6.3%	$80.1B
Current Assets	$8.8B-2.7%	$9.1B+8.3%	$8.4B-5.8%	$8.9B-13.0%	$10.2B+15.8%	$8.8B
Cash & Equivalents	$2.0B-7.4%	$2.1B+49.0%	$1.4B+44.9%	$984.0M-64.4%	$2.8B+37.6%	$2.0B
Inventory	$1.8B+3.8%	$1.8B-13.2%	$2.0B-1.8%	$2.1B+11.5%	$1.8B-2.7%	$1.9B
Accounts Receivable	$2.6B-9.3%	$2.8B-11.1%	$3.2B-25.4%	$4.3B+1.7%	$4.2B+99.0%	$2.1B
Goodwill	$668.0M0.0%	$668.0M	N/A	N/A	N/A	N/A
Total Liabilities	$48.2B-6.1%	$51.3B+17.2%	$43.8B+2.9%	$42.5B-22.3%	$54.7B-11.0%	$61.5B
Current Liabilities	$9.4B-1.0%	$9.5B+4.1%	$9.1B+17.9%	$7.8B-6.8%	$8.3B+1.2%	$8.2B
Long-Term Debt	$20.6B-17.4%	$25.0B+34.8%	$18.5B-5.8%	$19.7B-33.2%	$29.4B-17.7%	$35.7B
Total Equity	$36.0B+5.5%	$34.2B+12.9%	$30.3B+0.5%	$30.1B+48.0%	$20.3B+9.4%	$18.6B
Retained Earnings	$21.9B+3.3%	$21.2B+8.0%	$19.6B+19.0%	$16.5B+268.3%	$4.5B+49.5%	$3.0B

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Total Assets	$80.5B-4.4%	$84.2B+0.9%	$83.5B-1.1%	$84.4B-0.7%	$85.0B-0.6%	$85.4B-0.4%	$85.8B+12.6%	$76.2B
Current Assets	$11.1B+25.5%	$8.8B+0.2%	$8.8B-1.8%	$9.0B-7.6%	$9.7B+7.1%	$9.1B-5.1%	$9.6B-5.3%	$10.1B
Cash & Equivalents	$3.8B+93.6%	$2.0B-8.8%	$2.2B-7.2%	$2.3B-10.7%	$2.6B+22.5%	$2.1B+20.8%	$1.8B-4.7%	$1.8B
Inventory	$1.9B+2.1%	$1.8B-13.9%	$2.1B+13.0%	$1.9B-12.4%	$2.1B+21.8%	$1.8B-22.8%	$2.3B-19.1%	$2.8B
Accounts Receivable	$3.7B+42.8%	$2.6B-18.7%	$3.2B-8.6%	$3.5B-3.9%	$3.6B+27.1%	$2.8B-27.7%	$3.9B+0.7%	$3.9B
Goodwill	N/A	$668.0M	N/A	N/A	N/A	$668.0M	N/A	N/A
Total Liabilities	$41.5B-13.7%	$48.2B+2.0%	$47.2B-2.9%	$48.6B-3.2%	$50.3B-2.0%	$51.3B+0.3%	$51.1B+15.8%	$44.2B
Current Liabilities	$9.2B-2.9%	$9.4B+0.1%	$9.4B+10.0%	$8.6B-11.0%	$9.6B+1.1%	$9.5B-0.2%	$9.5B-1.6%	$9.7B
Long-Term Debt	$15.2B-26.1%	$20.6B-1.1%	$20.8B-10.7%	$23.3B-2.9%	$24.0B-3.8%	$25.0B-1.9%	$25.5B+38.4%	$18.4B
Total Equity	$38.9B+8.0%	$36.0B-0.6%	$36.3B+1.5%	$35.7B+2.9%	$34.7B+1.6%	$34.2B-1.5%	$34.7B+8.2%	$32.1B
Retained Earnings	$24.8B+13.3%	$21.9B-1.4%	$22.2B+1.9%	$21.8B+0.2%	$21.7B+2.5%	$21.2B-2.3%	$21.7B+3.6%	$20.9B

OXY Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$10.5B-7.9%	$11.4B-7.1%	$12.3B-26.8%	$16.8B+61.1%	$10.4B+163.8%	$4.0B
Capital Expenditures	$6.4B+2.6%	$6.3B+10.0%	$5.7B+26.7%	$4.5B+56.7%	$2.9B+13.2%	$2.5B
Free Cash Flow	$4.1B-20.7%	$5.2B-21.7%	$6.6B-46.3%	$12.3B+62.8%	$7.6B+432.7%	$1.4B
Investing Cash Flow	-$5.8B+60.3%	-$14.6B-109.0%	-$7.0B-43.3%	-$4.9B-288.8%	-$1.3B-53.0%	-$819.0M
Financing Cash Flow	-$4.8B-226.0%	$3.8B+178.6%	-$4.9B+64.3%	-$13.7B-60.0%	-$8.6B-89.8%	-$4.5B
Dividends Paid	N/A	N/A	N/A	$1.2B+41.1%	$839.0M-54.5%	$1.8B
Share Buybacks	$0-100.0%	$27.0M-98.5%	$1.8B-42.0%	$3.1B+38637.5%	$8.0M-33.3%	$12.0M

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Operating Cash Flow	$1.3B-51.4%	$2.6B-5.6%	$2.8B-5.7%	$3.0B+37.8%	$2.1B-36.0%	$3.4B-8.9%	$3.7B+53.8%	$2.4B
Capital Expenditures	$1.6B+106.4%	$753.0M-57.4%	$1.8B-20.5%	$2.2B+32.2%	$1.7B+63.9%	$1.0B-39.0%	$1.7B-5.0%	$1.8B
Free Cash Flow	-$273.0M-114.5%	$1.9B+84.1%	$1.0B+38.9%	$736.0M+57.9%	$466.0M-80.0%	$2.3B+16.6%	$2.0B+220.9%	$623.0M
Investing Cash Flow	$7.8B+533.6%	-$1.8B-43.8%	-$1.3B+37.0%	-$2.0B-173.5%	-$731.0M+59.2%	-$1.8B+80.4%	-$9.1B-387.4%	-$1.9B
Financing Cash Flow	-$7.3B-652.4%	-$974.0M+42.5%	-$1.7B-36.4%	-$1.2B-33.4%	-$932.0M+22.5%	-$1.2B-122.5%	$5.3B+13579.5%	$39.0M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$56.0M	$0	$0	$0	$0-100.0%	$18.0M	$0-100.0%	$9.0M

OXY Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	11.0%-3.0pp	14.0%-6.3pp	20.3%-16.0pp	36.3%+27.4pp	8.9%+92.2pp	-83.3%
Return on Equity	6.6%-2.4pp	9.0%-6.5pp	15.5%-28.7pp	44.2%+32.8pp	11.4%+91.3pp	-79.8%
Return on Assets	2.8%-0.8pp	3.6%-2.8pp	6.3%-12.0pp	18.3%+15.2pp	3.1%+21.6pp	-18.5%
Current Ratio	0.94-0.0	0.95+0.0	0.92-0.2	1.15-0.1	1.23+0.2	1.07
Debt-to-Equity	0.57-0.2	0.73+0.1	0.61-0.0	0.65-0.8	1.45-0.5	1.92
FCF Margin	19.0%-4.5pp	23.5%-5.0pp	28.5%-5.1pp	33.6%+4.5pp	29.1%+21.2pp	8.0%

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	64.2%+60.2pp	4.0%-8.7pp	12.7%+5.4pp	7.3%-9.3pp	16.6%+22.4pp	-5.8%-21.7pp	15.9%-1.3pp	17.2%
Return on Equity	8.6%+8.3pp	0.3%-2.0pp	2.3%+1.0pp	1.3%-1.4pp	2.7%+3.1pp	-0.4%-3.6pp	3.3%-0.4pp	3.6%
Return on Assets	4.2%+4.0pp	0.1%-0.9pp	1.0%+0.5pp	0.5%-0.6pp	1.1%+1.3pp	-0.1%-1.5pp	1.3%-0.2pp	1.5%
Current Ratio	1.21+0.3	0.940.0	0.94-0.1	1.05+0.0	1.01+0.1	0.95-0.0	1.00-0.0	1.04
Debt-to-Equity	0.39-0.2	0.570.0	0.57-0.1	0.65-0.0	0.69-0.0	0.730.0	0.73+0.2	0.57
FCF Margin	-5.2%-71.2pp	66.0%+50.6pp	15.4%+4.0pp	11.5%+3.3pp	8.2%-105.3pp	113.4%+85.6pp	27.9%+18.7pp	9.1%

Note: The current ratio is below 1.0 (0.94), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Hess Corp HES

$46.2B

Diamondback Ener FANG

$51.2B

Eog Res Inc EOG

$71.1B

Eqt Corp EQT

$31.4B

Canadian Natural Resources CNQ

$87.3B

Frequently Asked Questions

What is Occidental Pet's annual revenue?

Occidental Pet (OXY) reported $21.6B in total revenue for fiscal year 2025. This represents a -1.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Occidental Pet's revenue growing?

Occidental Pet (OXY) revenue declined by 1.9% year-over-year, from $22.0B to $21.6B in fiscal year 2025.

Is Occidental Pet profitable?

Yes, Occidental Pet (OXY) reported a net income of $2.4B in fiscal year 2025, with a net profit margin of 11.0%.

How much debt does Occidental Pet have?

As of fiscal year 2025, Occidental Pet (OXY) had $2.0B in cash and equivalents against $20.6B in long-term debt.

What is Occidental Pet's net profit margin?

Occidental Pet (OXY) had a net profit margin of 11.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Occidental Pet pay dividends?

Yes, Occidental Pet (OXY) paid $0.96 per share in dividends during fiscal year 2025.

What is Occidental Pet's return on equity (ROE)?

Occidental Pet (OXY) has a return on equity of 6.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Occidental Pet's free cash flow?

Occidental Pet (OXY) generated $4.1B in free cash flow during fiscal year 2025. This represents a -20.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Occidental Pet's operating cash flow?

Occidental Pet (OXY) generated $10.5B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Occidental Pet's total assets?

Occidental Pet (OXY) had $84.2B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Occidental Pet's capital expenditures?

Occidental Pet (OXY) invested $6.4B in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How many shares does Occidental Pet have outstanding?

Occidental Pet (OXY) had 986M shares outstanding as of fiscal year 2025.

What is Occidental Pet's current ratio?

Occidental Pet (OXY) had a current ratio of 0.94 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is Occidental Pet's debt-to-equity ratio?

Occidental Pet (OXY) had a debt-to-equity ratio of 0.57 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Occidental Pet's return on assets (ROA)?

Occidental Pet (OXY) had a return on assets of 2.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Occidental Pet's Piotroski F-Score?

Occidental Pet (OXY) has a Piotroski F-Score of 4 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Occidental Pet's earnings high quality?

Occidental Pet (OXY) has an earnings quality ratio of 4.45x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Occidental Pet?

Occidental Pet (OXY) scores 34 out of 100 on our Financial Health Score, indicating weak standing within its energy companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.